Progression of choroidal metastasis of ovarian serous cystoadenocarcinoma after intravitreal bevacizumab treatment

• Published in: Rare tumors Vol. 5; no. 1; pp. 18 - 20
• Main Authors: Kuo, Irene C., Sambuelli, Ruben H., Bono, Javier, Smith, Ricardo J., Reviglio, Victor E.
• Format: Journal Article
• Language: English
• Published: Pavia, Italy PAGEPress Publications 04-03-2013; SAGE Publishing
• Subjects: Case Report; ovarian serous cystoadenocarcinoma, choroidal metastasis, intravitreal bevacizumab
• ISSN: 2036-3613; 2036-3605; 2036-3603; 2036-3613
• DOI: 10.4081/rt.2013.e5

A 57-year-old woman presented to her ophthalmologist because of rapid deterioration in vision. Dilated funduscopic examination of the right eye showed an elevated, yellow-orange choroidal mass temporal to the fovea; a complete retinal detachment was present in the left eye. The patient was referred to an oncologist. Computerized tomography of the brain, thorax, abdomen, and pelvis were obtained. They revealed an 11-mm mass in the right parietal lobe, a 30-mm mass in the left temporal lobe, 23-mm mass in the right kidney, and multiple nodules in both lungs. Supported by published experience with intravitreal bevacizumab for choroidal metastasis, the patient was injected into the vitreous through the pars plana of the left eye. The tumor mass did not show signs of regression and the visual acuity was unchanged. The patient suffered from end-state complications tumor metastasis and expired one month after the invitreal injection.